Announcements

We are delighted to share some highly viewed papers on cancer biomarkers that were published in the journal Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

1. “Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis”
by Taha Koray Sahin, Alessandro Rizzo, Sercan Aksoy and Deniz Can Guven
Cancers 2024, 16(10), 1835; https://doi.org/10.3390/cancers16101835
Available online: https://www.mdpi.com/2072-6694/16/10/1835

2. “Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy”
by Chloe Springer, Danish Humayun and Rachid Skouta
Cancers 2024, 16(3), 647; https://doi.org/10.3390/cancers16030647
Available online: https://www.mdpi.com/2072-6694/16/3/647

3. “Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma”
by Lena Nanz, Ulrike Keim, Alexander Katalinic, Thomas Meyer, Claus Garbe and Ulrike Leiter
Cancers 2024, 16(3), 606; https://doi.org/10.3390/cancers16030606
Available online: https://www.mdpi.com/2072-6694/16/3/606

4. “Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?”
by Maria Cecília Mathias-Machado, Victor Hugo Fonseca de Jesus, Alexandre Jácome, Mauro Daniel Donadio, Marcelo Porfirio Sunagua Aruquipa, João Fogacci, Renato Guerino Cunha, Leonard Medeiros da Silva and Renata D’Alpino Peixoto
Cancers 2024, 16(3), 679; https://doi.org/10.3390/cancers16030679
Available online: https://www.mdpi.com/2072-6694/16/3/679

5. “ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer”
by Aakash Desai, Tadana A. Vázquez, Keishla M. Arce, Marcelo Corassa, Philip C. Mack, Jhanelle E. Gray and Bruna Pellini
Cancers 2024, 16(5), 940; https://doi.org/10.3390/cancers16050940
Available online: https://www.mdpi.com/2072-6694/16/5/940

6. “Upper Tract Urothelial Cancer: Guideline of Guidelines”
by Savio Domenico Pandolfo, Simone Cilio, Achille Aveta, Zhenjie Wu, Clara Cerrato, Luigi Napolitano, Francesco Lasorsa, Giuseppe Lucarelli, Paolo Verze, Salvatore Siracusano et al.
Cancers 2024, 16(6), 1115; https://doi.org/10.3390/cancers16061115
Available online: https://www.mdpi.com/2072-6694/16/6/1115

Special Issues:

“Views and Perspectives of Cutaneous Squamous Cell Carcinoma”
Guest Editors: Dr. Thomas Meyer and Dr. Alexandra Geusau
Viewed by: 24770+
Submission deadline: 30 June 2025

“Novel Biomarkers in Non-Small Cell Lung Cancer (NSCLC)”
Guest Editor: Dr. Alfredo Tartarone
Viewed by:  20730+
Submission deadline: 30 June 2025

“Pre-Clinical Studies of Personalized Medicine for Cancer Research”
Guest Editor:  Dr. Nuno Vale
Viewed by:  35200+
Submission deadline: 30 June 2025

“Predictive Biomarkers for Colorectal Cancer”
Guest Editor:  Dr. Mitsukuni Suenaga
Viewed by:  19910+
Submission deadline: 21 March 2025

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share some highly viewed papers on cancer metastasis that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

“A Systematic Review on Artificial Intelligence Evaluating Metastatic Prostatic Cancer and Lymph Nodes on PSMA PET Scans”
by Jianliang Liu, Thomas P. Cundy, Dixon T. S. Woon and Nathan Lawrentschuk
Cancers 2024, 16(3), 486; https://doi.org/10.3390/cancers16030486
Available online: https://www.mdpi.com/2072-6694/16/3/486

“Novel Therapeutic Targets on the Horizon: An Analysis of Clinical Trials on Therapies for Bone Metastasis in Prostate Cancer”
by Wenhao Zhou, Wei Zhang, Shi Yan, Kaixuan Zhang, Han Wu, Hongyu Chen, Minfeng Shi and Tie Zhou
Cancers 2024, 16(3), 627; https://doi.org/10.3390/cancers16030627
Available online: https://www.mdpi.com/2072-6694/16/3/627

“Role of Hypoxia and Rac1 Inhibition in the Metastatic Cascade”
by Enikő Tátrai, Ivan Ranđelović, Sára Eszter Surguta and József Tóvári
Cancers 2024, 16(10), 1872; https://doi.org/10.3390/cancers16101872
Available online: https://www.mdpi.com/2072-6694/16/10/1872

“Circulating Tumour Cells in the Prediction of Bone Metastasis”
by Siu-Wai Choi, Aria Kaiyuan Sun, Jason Pui-Yin Cheung and Jemmi Ching-Ying Ho
Cancers 2024, 16(2), 252; https://doi.org/10.3390/cancers16020252
Available online: https://www.mdpi.com/2072-6694/16/2/252

“The Effect of Non-Overlapping Somatic Mutations in BRAF, NRAS, NF1, or CKIT on the Incidence and Outcome of Brain Metastases during Immune Checkpoint Inhibitor Therapy of Metastatic Melanoma”
by Wolfram Samlowski
Cancers 2024, 16(3), 594;https://doi.org/10.3390/cancers16030594
Available online: https://www.mdpi.com/2072-6694/16/3/594

“Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status”
by Walid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, Alexander Yakobson, Yulia Dudnik, Ashraf Abu Jama, Ahron Yehonatan Cohen, Sondos Shalata, Ahmad Abu Hamed, Tahel Ilan Ber et al.
Cancers 2024, 16(10), 1825https://doi.org/10.3390/cancers16101825
Available online: https://www.mdpi.com/2072-6694/16/10/1825

Special Issues:

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share some highly viewed papers featuring systematic reviews or meta-analyses in cancer research that were published in the journal Cancers (ISSN: 2072-6694) in 2024. The following is a list of articles that we believe will be of interest to you.

1. “An Evidence-Based Update on the Potential for Malignancy of Oral Lichen Planus and Related Conditions: A Systematic Review and Meta-Analysis”
by Miguel Ángel González-Moles and Pablo Ramos-García
Cancers 2024, 16(3), 608; https://doi.org/10.3390/cancers16030608
Available online: https://doi.org/10.3390/cancers16030608

2. “Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood–Brain Barrier Disruption”
by Miłosz Pinkiewicz, Mateusz Pinkiewicz, Jerzy Walecki, Artur Zaczyński and Michał Zawadzki
Cancers 2024, 16(1), 236; https://doi.org/10.3390/cancers16010236
Available online: https://doi.org/10.3390/cancers16010236

3. “Is Unplanned Excision of Soft Tissue Sarcomas Associated with Worse Oncological Outcomes?—A Systematic Review and Meta-Analysis”
by Felipe Larios, Marcos R. Gonzalez, Kim Ruiz-Arellanos, George Aquilino E Silva and Juan Pretell-Mazzini
Cancers 2024, 16(2), 443; https://doi.org/10.3390/cancers16020443
Available online: https://doi.org/10.3390/cancers16020443

4. “Incidence of Cutaneous Immune-Related Adverse Events and Outcomes in Immune Checkpoint Inhibitor-Containing Regimens: A Systematic Review and Meta-Analysis”
by Nina B. Curkovic, Kun Bai and Douglas B. Johnson
Cancers 2024, 16(2), 340; https://doi.org/10.3390/cancers16020340
Available online: https://doi.org/10.3390/cancers16020340

5. “Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis”
by Michela Roberto, Giacomo Barchiesi, Blerina Resuli, Monica Verrico, Iolanda Speranza, Leonardo Cristofani, Federica Pediconi, Federica Tomao, Andrea Botticelli and Daniele Santini
Cancers 2024, 16(3), 596; https://doi.org/10.3390/cancers16030596
Available online: https://doi.org/10.3390/cancers16030596

6. “Risk Prediction Models for Oral Cancer: A Systematic Review”
by Aufia Espressivo, Z. Sienna Pan, Juliet A. Usher-Smith and Hannah Harrison
Cancers 2024, 16(3), 617; https://doi.org/10.3390/cancers16030617
Available online: https://doi.org/10.3390/cancers16030617

7. “Hypoxic Signaling Pathways in Carotid Body Tumors”
by Kangxi Cao, Wanzhong Yuan, Chaofan Hou, Zhongzheng Wang, Jiazhi Yu and Tao Wang
Cancers 2024, 16(3), 584; https://doi.org/10.3390/cancers16030584
Available online: https://doi.org/10.3390/cancers16030584

8. “Evaluating Radar Reflector Localisation in Targeted Axillary Dissection in Patients Undergoing Neoadjuvant Systemic Therapy for Node-Positive Early Breast Cancer: A Systematic Review and Pooled Analysis”
by Umar Wazir, Michael J. Michell, Munaser Alamoodi and Kefah Mokbel
Cancers 2024, 16(7), 1345; https://doi.org/10.3390/cancers16071345
Available online: https://doi.org/10.3390/cancers16071345

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share some highly viewed papers on tumor microenvironment that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway”
by Vasiliki Zoi, Athanassios P. Kyritsis, Vasiliki Galani, Diamanto Lazari, Chrissa Sioka, Spyridon Voulgaris and Georgios A. Alexiou
Cancers 2024, 16(8), 1554; https://doi.org/10.3390/cancers16081554
Available online: https://www.mdpi.com/2072-6694/16/8/1554

“Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth”
by Marilyn Mathew, Nhi T. Nguyen, Yangzom D. Bhutia, Sathish Sivaprakasam and Vadivel Ganapathy
Cancers 2024, 16(3), 504; https://doi.org/10.3390/cancers16030504
Available online: https://www.mdpi.com/2072-6694/16/3/504

“The Matrix Stiffness Coordinates the Cell Proliferation and PD-L1 Expression via YAP in Lung Adenocarcinoma”
by Yeonhee Park, Dahye Lee, Jeong Eun Lee, Hee Sun Park, Sung Soo Jung, Dongil Park, Da Hyun Kang, Song-I Lee, Seong-Dae Woo and Chaeuk Chung
Cancers 2024, 16(3), 598; https://doi.org/10.3390/cancers16030598
Available online: https://www.mdpi.com/2072-6694/16/3/598

“Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression”
by Raffaele Strippoli, Reyhaneh Niayesh-Mehr, Maryam Adelipour, Arezoo Khosravi, Marco Cordani, Ali Zarrabi and Abdolamir Allameh
Cancers 2024, 16(4), 807; https://doi.org/10.3390/cancers16040807
Available online: https://www.mdpi.com/2072-6694/16/4/807

“CSF-1R in Cancer: More than a Myeloid Cell Receptor”
by Francesca Cersosimo, Silvia Lonardi, Cristina Ulivieri, Paolo Martini, Andrea Morrione, William Vermi, Antonio Giordano and Emanuele Giurisato
Cancers 2024, 16(2), 282; https://doi.org/10.3390/cancers16020282
Available online: https://www.mdpi.com/2072-6694/16/2/282

“Therapeutic Immunomodulation in Gastric Cancer”

by Venu Akkanapally, Xue-Feng Bai and Sujit Basu
Cancers 2024, 16(3), 560; https://doi.org/10.3390/cancers16030560
Available online: https://www.mdpi.com/2072-6694/16/3/560

Special Issues:

“Oncogenic Driver Mutations and Signaling Pathways in Tumorigenesis and Therapy in Lung Cancer” Guest Editor: Dr. Lei Duan Submission deadline: 31 May 2025	“Human Microbiome, Diet and Cancerogenesis” Guest Editor: Prof. Dr. Ewa Brzeziańska-Lasota Submission deadline: 31 May 2025
“Lifestyle Choices and Endocrine Dysfunction on Cancer Onset and Risk” Guest Editors: Dr. Ariane Zamoner, Dr. Marco G. Alves and Dr. Ana Paula S. Perez Submission deadline: 1 June 2025	“Aging and Cancers” Guest Editors: Dr. Fabio Marongiu and Dr. Saloni Sinha Submission deadline: 30 June 2025

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share some highly viewed papers on cancer immunology and immunotherapy that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“Dendritic Cells in Cancer Immunology and Immunotherapy”
by Laura Hato, Angel Vizcay, Iñaki Eguren, José L. Pérez-Gracia, Javier Rodríguez, Jaime Gállego Pérez-Larraya, Pablo Sarobe, Susana Inogés, Ascensión López Díaz de Cerio and Marta Santisteban
Cancers 2024, 16(5), 981; https://doi.org/10.3390/cancers16050981
Available online: https://www.mdpi.com/2072-6694/16/5/981

“Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives”
by Ilaria Salvato and Antonio Marchini
Cancers 2024, 16(7), 1276; https://doi.org/10.3390/cancers16071276
Available online: https://www.mdpi.com/2072-6694/16/7/1276

“Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings”
by Daniel Park, Won Jin Jeon, Chieh Yang and Dani Ran Castillo
Cancers 2024, 16(2), 318; https://doi.org/10.3390/cancers16020318
Available online: https://www.mdpi.com/2072-6694/16/2/318

“The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review”
by Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, Marina Cipullo, Mario Romeo, Giovanna Palladino, Patrizia Iodice, Alessandro Federico and Teresa Troiani
Cancers 2024, 16(3), 611; https://doi.org/10.3390/cancers16030611
Available online: https://www.mdpi.com/2072-6694/16/3/611

“Triple Negative Breast Cancer: Molecular Subtype-Specific Immune Landscapes with Therapeutic Implications”
by Antonia Syrnioti, Stamatios Petousis, Lisa A. Newman, Chrysoula Margioula-Siarkou, Theodora Papamitsou, Konstantinos Dinas and Triantafyllia Koletsa
Cancers 2024, 16(11), 2094; https://doi.org/10.3390/cancers16112094
Available online: https://www.mdpi.com/2072-6694/16/11/2094

“Preclinical Evaluation of Novel Folate Receptor 1-Directed CAR T Cells for Ovarian Cancer”
by Julie Daigre, Manuel Martinez-Osuna, Maria Bethke, Larissa Steiner, Vera Dittmer, Katrin Krischer, Cathrin Bleilevens, Janina Brauner, Jens Kopatz, Matthias David Grundmann et al.
Cancers 2024, 16(2), 333; https://doi.org/10.3390/cancers16020333
Available online: https://www.mdpi.com/2072-6694/16/2/333

Special Issues:

“Oncolytic Viruses as an Emerging Aspect of Immune Oncology”
Guest Editor: Dr. Jennifer Altomonte
Submission deadline: 31 March 2025

“Immunotherapy with Checkpoint Inhibitors for Non-small Cell Lung Cancer”
Guest Editors: Dr. Alessandro Inno and Dr. Diego Signorelli
Submission deadline: 31 March 2025

“Evidence from the Real World Provides New Insights into the Evolving Landscape of Cancer Immunotherapy”
Guest Editors: Dr. Fabrizio Nelli, Dr. Carlo Signorelli, and Dr. Enzo Ruggeri
Submission deadline: 30 April 2025

“How to Properly Diagnose and Treat Immune-Related Adverse Events during Immunotherapy in Patients with Cancer: Discussion between Specialists”
Guest Editors: Dr. Angioletta Lasagna and Dr. Paolo Sacchi
Submission deadline: 30 April 2025

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share some highly viewed papers on infectious agents and cancer that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review”
by Caroline Amélia Gonçalves, Gabriela Pereira-da-Silva, Renata Cristina Campos Pereira Silveira, Paulo César Morales Mayer, Adriana Zilly and Luís Carlos Lopes-Júnior
Cancers 2024, 16(3), 672; https://doi.org/10.3390/cancers16030672
Available online: https://www.mdpi.com/2072-6694/16/3/672

“Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers”
by Atharva S. Torne and Erle S. Robertson
Cancers 2024, 16(5), 991; https://doi.org/10.3390/cancers16050991
Available online: https://www.mdpi.com/2072-6694/16/5/991

“PAX1/JAM3 Methylation and HPV Viral Load in Women with Persistent HPV Infection”
by Mingzhu Li, Chao Zhao, Xiaobo Zhang, Jingran Li, Yun Zhao, Wei Zhang, Lihua Ren and Lihui Wei
Cancers 2024, 16(7), 1430; https://doi.org/10.3390/cancers16071430
Available online: https://www.mdpi.com/2072-6694/16/7/1430

“Precision Medicine for Nasopharyngeal Cancer—A Review of Current Prognostic Strategies”
by Luvita Suryani, Hazel P. Y. Lee, Wei Keat Teo, Zhi Kang Chin, Kwok Seng Loh and Joshua K. Tay
Cancers 2024, 16(5), 918; https://doi.org/10.3390/cancers16050918
Available online: https://www.mdpi.com/2072-6694/16/5/918

“Cancer and HIV: The Molecular Mechanisms of the Deadly Duo”
by Aadilah Omar, Natasia Marques and Nicole Crawford
Cancers 2024, 16(3), 546; https://doi.org/10.3390/cancers16030546
Available online: https://www.mdpi.com/2072-6694/16/3/546

“Cultivable Microbiome Approach Applied to Cervical Cancer Exploration”
by Irma Berenice Mulato-Briones, Ismael Olan Rodriguez-Ildefonso, Julián Antonio Jiménez-Tenorio, Patricia Isidra Cauich-Sánchez, María del Socorro Méndez-Tovar, Gerardo Aparicio-Ozores, María Yicel Bautista-Hernández, Juan Francisco González-Parra, Jesús Cruz-Hernández, Ricardo López-Romero et al.
Cancers 2024, 16(2), 314; https://doi.org/10.3390/cancers16020314
Available online: https://www.mdpi.com/2072-6694/16/2/314

Special Issues:

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are pleased to announce that eight new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694), joining in November 2024. We wish our new members success in both their research and their efforts to develop the journal.

Name: Dr. Salvatore Lopez
Affiliation: Ginecologia Oncologica, I.R.C.C.S. Istituto Tumori Giovanni Paolo II, Bari, Italy
Interests: gynecological oncology; translational oncology; immunotherapy

Name: Prof. Dr. Maxim V. Berezovski
Affiliation: Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N 6N5, Canada
Interests: glioblastoma; lung cancer; molecular diagnostics; circulating tumor cells; tumor-derived exosomes; aptamers; proteomics; biomarkers

Name: Dr. Norikatsu Miyoshi
Affiliation: Department of Gastroenterological Surgery, Osaka University, Osaka 565-0971, Japan
Interests: gastrointestinal surgery; colorectal cancer; oncogene; oncological prognosis

Name: Dr. Kathy Gately
Affiliation: Department of Clinical Medicine, Trinity College, DO8 W9RT Dublin, Ireland
Interests: drug resistance mechanisms; PIM kinase; PI3K-mTOR pathway; precision medicine; lung cancer

Name: Prof. Dr. Jayanth Panyam
Affiliation: Professor and Dean, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140, USA
Interests: targeted drug delivery; nanoparticles; antibody–drug conjugates; controlled release; chemoprevention; immunotherapy; cancer vaccine

Name: Dr. Steven G. Gray
Affiliation: Thoracic Oncology Research Group, Trinity Translational Medicine Institute, Trinity Centre for Health Sciences, St James’s Hospital, D08 W9RT Dublin, Ireland
Interests: epigenetics; non-coding RNA; thoracic malignancy; lung cancer; mesothelioma; receptor tyrosine kinases; drug resistance

Name: Prof. Dr. Daniele Santini
Affiliations: ¹ Oncologia Medica A, Policlinico Umberto 1, La Sapienza Università Di, 00161 Roma, Italy; ² Department of Medico-Surgical Sciences and Biotechnology, Sapienza University of Rome, 00161 Rome, Italy
Interests: hepatocellular carcinoma; bone metastasis; colorectal tumors; kidney tumors; gastric cancers

Name: Dr. Sergio Marchini
Affiliation: Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy
Interests: cancer biology; gene expression; NGS; mesotheliomas; trabectedin translational research; ovarian cancer

Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.

Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office (cancers@mdpi.com) and provide the following files:

• A full academic CV;
• A short cover letter detailing your interest in the position.

We are delighted to share some highly viewed papers and hot topic Special Issues on molecular cancer biology that were published in the journal Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submissions. The following is a list of articles and Special Issues which we believe will be of interest to you. The list of relevant papers can be seen below:

“MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges”
by Anju G. S. Phoolchund and Salim I. Khakoo
Cancers 2024, 16(2), 259; https://doi.org/10.3390/cancers16020259
Available online: https://www.mdpi.com/2072-6694/16/2/259

“Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells”
by Youssef Al Hmada, Robert T. Brodell, Naji Kharouf, Thomas W. Flanagan, Abdulhadi A. Alamodi, Sofie-Yasmin Hassan, Hosam Shalaby, Sarah-Lilly Hassan, Youssef Haikel, Mosaad Megahed et al.
Cancers 2024, 16(2), 470; https://doi.org/10.3390/cancers16020470
Available online: https://www.mdpi.com/2072-6694/16/2/470 

“Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer”
by Qiao-Hong Chen, Erick Munoz and Dennis Ashong
Cancers 2024, 16(3), 663; https://doi.org/10.3390/cancers16030663
Available online: https://www.mdpi.com/2072-6694/16/3/663

“The Role of Circulating Tumor Cells as a Liquid Biopsy for Cancer: Advances, Biology, Technical Challenges, and Clinical Relevance”
by Tyler A. Allen
Cancers 2024, 16(7), 1377; https://doi.org/10.3390/cancers16071377
Available online: https://www.mdpi.com/2072-6694/16/7/1377

“Plant-Derived Polyphenols to Prevent and Treat Oral Mucositis Induced by Chemo- and Radiotherapy in Head and Neck Cancers Management”
by Elena Belfiore, Giulia Di Prima, Giuseppe Angellotti, Vera Panzarella and Viviana De Caro
Cancers 2024, 16(2), 260; https://doi.org/10.3390/cancers16020260
Available online: https://www.mdpi.com/2072-6694/16/2/260

“The Versatile Attributes of MGMT: Its Repair Mechanism, Crosstalk with Other DNA Repair Pathways, and Its Role in Cancer”
by Qingming Fang
Cancers 2024, 16(2), 331; https://doi.org/10.3390/cancers16020331
Available online: https://www.mdpi.com/2072-6694/16/2/331

Special Issues:
“Molecular Insights into Drug Resistance in Cancer”
Guest Editor: Dr. Yang Yuqi
Submission deadline: 31 May 2025

“Lung Cancer—Molecular Insights and Targeted Therapies (Volume II)”
Guest Editor: Dr. Sonia Molina-Pinelo
Submission deadline: 30 June 2025

“Advances in Genetic and Molecular Approaches to Skin Cancer”
Guest Editor: Dr. Egle Ramelyte
Submission deadline: 30 June 2025 

“Molecular Pathology of Brain Tumors”
Guest Editor: Prf. Dr. Ho-Keung NG
Submission deadline: 30 April 2025

We hope this announcement will provide useful information for the field of molecular cancer biology.

Cancers Editorial Office

We are delighted to share some highly viewed papers on cancer pathophysiology that were published in the journal Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

“Molecular Characterization and Xenotransplantation of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA)”
by Lilia Antonova, Piriya Paramanthan, Theresa Falls, Marie-Eve Wedge, Justin Mayer, Harman S. Sekhon, John McPherson, Robert E. Denroche, Steven Gallinger, John Cameron Bell et al.
Cancers 2024, 16(15), 2721; https://doi.org/10.3390/cancers16152721
Available online: https://www.mdpi.com/2072-6694/16/15/2721

“Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma”
by Centura R. Anbarasu, Sophia Williams-Perez, Ernest R. Camp and Derek J. Erstad
Cancers 2024, 16(16), 2773; https://doi.org/10.3390/cancers16162773
Available online: https://www.mdpi.com/2072-6694/16/16/2773

“Prognostic Significance of Elevated UCHL1, SNRNP200, and PAK4 Expression in High-Grade Clear Cell Renal Cell Carcinoma: Insights from LC-MS/MS Analysis and Immunohistochemical Validation”
by Michał Kasperczak, Gabriel Bromiński, Iga Kołodziejczak-Guglas, Andrzej Antczak and Maciej Wiznerowicz
Cancers 2024, 16(16), 2844; https://doi.org/10.3390/cancers16162844
Available online: https://www.mdpi.com/2072-6694/16/16/2844

“Impact of Breast Cancer on Cardiometabolic Health in Spanish Women ≥50 Years with Pre-Existing Type 2 Diabetes Mellitus”
by Lucía Fernández-Arce, Nena Robles-Rodríguez, Ana Fernández-Feito, Rocío Fernández-Iglesias, María del Mar Fernández-Álvarez and Alberto Lana
Cancers 2024, 16(16), 2853; https://doi.org/10.3390/cancers16162853
Available online: https://www.mdpi.com/2072-6694/16/16/2853

“Inter-Ethnic Variations in the Clinical, Pathological, and Molecular Characteristics of Wilms Tumor”
by Kia Teng Lim and Amos H. P. Loh
Cancers 2024, 16(17), 3051; https://doi.org/10.3390/cancers16173051
Available online: https://www.mdpi.com/2072-6694/16/17/3051

“Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer”
by Noémie Thomas, Soizic Garaud, Mireille Langouo, Doïna Sofronii, Anaïs Boisson, Alexandre De Wind, Valérie Duwel, Ligia Craciun, Dennis Larsimont, Ahmad Awada et al.
Cancers 2024, 16(16), 2895; https://doi.org/10.3390/cancers16162895
Available online: https://www.mdpi.com/2072-6694/16/16/2895

We hope this announcement will provide useful information for the field of cancer pathophysiology.

Cancers Editorial Office

We are delighted to share some highly viewed papers on clinical research of cancer that were published in the journal Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

“Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma”
by Sami Fares, Chase J. Wehrle, Hanna Hong, Keyue Sun, Chunbao Jiao, Mingyi Zhang, Abby Gross, Erlind Allkushi, Melis Uysal, Suneel Kamath et al.
Cancers 2024, 16(8), 1453; https://doi.org/10.3390/cancers16081453
Available online: https://www.mdpi.com/2072-6694/16/8/1453

“Atypical Endometrial Hyperplasia and Concurrent Cancer: A Comprehensive Overview on a Challenging Clinical Condition”
by Luca Giannella, Camilla Grelloni, Marco Bernardi, Camilla Cicoli, Federica Lavezzo, Gianmarco Sartini, Leonardo Natalini, Mila Bordini, Martina Petrini, Jessica Petrucci et al.
Cancers 2024, 16(5), 914; https://doi.org/10.3390/cancers16050914
Available online: https://www.mdpi.com/2072-6694/16/5/914

“Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: A Comparison of Palliative with Bridging-to-Transplant Concepts”
by Jacqueline Schönherr, Philipp Seifert, Falk Gühne, Thomas Winkens, Falk Rauchfuß, Utz Settmacher, Martin Freesmeyer and Robert Drescher
Cancers 2024, 16(1), 235; https://doi.org/10.3390/cancers16010235
Available online: https://www.mdpi.com/2072-6694/16/1/235

“Venetoclax Resistance in Acute Myeloid Leukemia”
by Sylvain Garciaz, Marie-Anne Hospital, Yves Collette and Norbert Vey
Cancers 2024, 16(6), 1091; https://doi.org/10.3390/cancers16061091
Available online: https://www.mdpi.com/2072-6694/16/6/1091

“Emerging Therapies for Glioblastoma”
by Stella Aimé Rios, Stephanie Oyervides, David Uribe, Angelica Maree Reyes, Victor Fanniel, Jonathan Vazquez and Megan Keniry
Cancers 2024, 16(8), 1485; https://doi.org/10.3390/cancers16081485
Available online: https://www.mdpi.com/2072-6694/16/8/1485

“Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma”
by Omar Nadeem, Sikander Ailawadhi, Jack Khouri, Louis Williams, Donna Catamero, Kathryn Maples and Jesús Berdeja
Cancers 2024, 16(5), 1023; https://doi.org/10.3390/cancers16051023
Available online: https://www.mdpi.com/2072-6694/16/5/1023

We hope this announcement will provide useful information for the field of clinical research of cancer.

Cancers Editorial Office